Company Filing History:
4 out of 426 
2 out of 722 
1 out of 13 Years Active: 1984-2008
Title: The Innovative Contributions of Donald A Randolph
Introduction
Donald A Randolph, based in Wheaton, IL, is a distinguished inventor with a remarkable portfolio of seven patents. His work primarily revolves around advancements in biomedical materials, particularly in the field of bone graft substitutes and controlled release systems. His innovative contributions have significantly impacted medical technologies, providing solutions that are beneficial in clinical practices.
Latest Patents
Among Randolph's most notable inventions is the Bone Graft Substitute Composition. This composition includes calcium sulfate and a variety of mixing solutions, aimed at enhancing bone regeneration. Furthermore, he has developed the Calcium Sulfate Controlled Release Matrix, which focuses on the controlled release of calcium sulfate, along with potential additives like medicaments or pesticides. This pellet construction is designed to control dissolution rates and ensure targeted delivery within biological systems, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Randolph has been associated with reputable companies such as Wright Medical Technology, Inc. and the United States Gypsum Company. His extensive experience within these organizations has allowed him to contribute to pivotal projects that bridge the gap between materials science and healthcare.
Collaborations
In his journey as an inventor, Randolph has collaborated with notable colleagues, including Jodi L Negri and Timothy R Devine. These partnerships have fostered an environment of creativity and innovation, enabling the development of groundbreaking solutions within the medical field.
Conclusion
Donald A Randolph's innovative spirit and dedication to improving medical technologies through his inventions have established him as a prominent figure in his field. His patents not only demonstrate his technical expertise but also reflect his commitment to addressing crucial medical challenges through innovation.